TPQD
a novel pharmaceutical compound with strong preliminary data for animal and human health
Opportunity:
Many neurological diseases have causes in mitochondrial dysfunction with no current treatments. These diseases cause millions of dollars in expenses to Americans.
In addition to
Multiple Disease Targets for human health
Preliminary data strongly suggests TPQD may resolve disorders such as EPM in Equine cases and similar diseases in companion animals.
